2009
DOI: 10.1111/j.1651-2227.2009.01413.x
|View full text |Cite
|
Sign up to set email alerts
|

Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia

Abstract: The Scandinavian approach is an effective combined treatment for respiratory distress syndrome (RDS) and prevention of bronchopulmonary dysplasia (BPD). It is composed of many individual parts.Of significant importance is the early treatment with nasal continuous positive airway pressure (nCPAP) and surfactant treatment. The approach may be supplemented with caffeine citrate and non-invasive positive pressure ventilation for apnoea. The low incidence of BPD seen as a consequence of the treatment strategy is ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
48
0
6

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(54 citation statements)
references
References 95 publications
(137 reference statements)
0
48
0
6
Order By: Relevance
“…1 Respiratory distress syndrome (RDS) is common in preterm infants born at Ͻ 32 weeks of gestational age, [2][3][4] and surfactant and mechanical ventilation have been the standard treatment. 5 However, despite advances in neonatal respiratory care, a considerable number of preterm infants develop chronic lung disease, termed bronchopulmonary dysplasia (BPD), [5][6][7][8] that is associated with neonatal death, prolonged NICU stay, and impaired neurodevelopment. 9 BPD has a multifactorial pathogenesis, and invasive mechanical ventilation is one of its most important causes.…”
Section: Introductionmentioning
confidence: 99%
“…1 Respiratory distress syndrome (RDS) is common in preterm infants born at Ͻ 32 weeks of gestational age, [2][3][4] and surfactant and mechanical ventilation have been the standard treatment. 5 However, despite advances in neonatal respiratory care, a considerable number of preterm infants develop chronic lung disease, termed bronchopulmonary dysplasia (BPD), [5][6][7][8] that is associated with neonatal death, prolonged NICU stay, and impaired neurodevelopment. 9 BPD has a multifactorial pathogenesis, and invasive mechanical ventilation is one of its most important causes.…”
Section: Introductionmentioning
confidence: 99%
“…Estos resultados se unen a los de muchas otras series citadas en la literatura científica, en las que se ha encontrado que la CPAP disminuye la incidencia de displasia broncopulmonar (3,4,(6)(7)(8)18,19,21,24,32,33). En otros estudios no se han encontrado diferencias en la incidencia de la displasia broncopulmonar, pero en ninguno de ellos se empleó la misma intervención evaluada en el presente estudio.…”
Section: Discussionunclassified
“…En los metaanálisis publicados en los últimos años, que incluyen gran cantidad de estudios sobre intervenciones sin uso de surfactante, se concluye que: la CPAP reduce el tiempo de intervención de la enfermedad de membrana hialina; que es equivalente a la respiración mecánica en cuanto a mortalidad, presencia de enterocolitis necrosante y hemorragia intraventricular (con la ventaja de que puede usarse incluso en prematuros muy pequeños), y que la gravedad de la displasia broncopulmonar es menor, por lo que también se reduce el uso de oxígeno y esteroides (1,2,(4)(5)(6)(7)(8).…”
unclassified
See 1 more Smart Citation
“…11 Thus, the incidence of BPD was very low in centers that introduced INSURE compared with centers using MV and rescue surfactant. 12 An US group reduced the incidence of chronic lung disease in infants with birth weight <1500 g by avoiding intubation in the delivery room, adoption of new pulse oximeter limits and very early use of NCPAP and surfactant, 13 and in a randomized study comparing INSURE with NCPAP, the incidence of BPD, MV and air leaks was less in the INSURE group. 7 In studies using primary MV, the incidence of BPD was lower following prophylactic surfactant than after rescue treatment with surfactant, 14 and early selective surfactant treatment reduced the combined mortality and BPD more effectively than the rescue treatment.…”
mentioning
confidence: 99%